2014
DOI: 10.3855/jidc.4704
|View full text |Cite
|
Sign up to set email alerts
|

An overview of extended-spectrum beta-lactamases in veterinary medicine and their public health consequences

Abstract: Serious human and animal infections caused by bacteria are usually treated with beta-lactams. Extended-spectrum beta-lactamases (ESBLs) constitute the most clinically and economically important enzymes that are able to hydrolyze and inactivate beta-lactam antibiotics in veterinary medicine. The spread of ESBLs represents a serious threat to healthcare systems, drastically undermining therapeutic options. The relationship between drug usage and the emergence of resistance has been extensively reported. Neverthe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
14
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 55 publications
0
14
0
Order By: Relevance
“…Guidelines for alternative therapies, monitoring programs, and development of preventive medicine will decrease the spread of ESBLs in veterinary medicine. Together, these strategies could certainly reduce the impact of several multidrugs resistance microorganisms on animal health [18].…”
Section: A C C E P T E D Accepted Manuscriptmentioning
confidence: 99%
“…Guidelines for alternative therapies, monitoring programs, and development of preventive medicine will decrease the spread of ESBLs in veterinary medicine. Together, these strategies could certainly reduce the impact of several multidrugs resistance microorganisms on animal health [18].…”
Section: A C C E P T E D Accepted Manuscriptmentioning
confidence: 99%
“…The problem is that the use of antibiotics in animals increases the size of the gene pool to further the emergence of multi-resistant enterococci causing human infections (Bates, 1997). Evidence of potential relationships between the use of animal drugs with resistant bacteria affecting humans have been established by a number of researchers (Alba et al, 2015;Argudín et al, 2015;Feßler et al, 2012;Graveland et al, 2010;Nóbrega and Brocchi, 2014;Schmithausen et al, 2015).…”
Section: The Need For the Vfd: Human Acquired Antibiotic Resistance Fmentioning
confidence: 99%
“…Beta-lactams (penicillins, cephalosporins, carbapenems, and monobactams) constitute the therapy of choice for some well-established practices and infections in veterinary medicine [2]. The third generation of cephalosporins has been associated with the emergence of beta-lactamases mediated bacterial resistance, which subsequently led to the development of extended spectrum beta-lactamase (ESBL)-producing bacteria.…”
Section: Introductionmentioning
confidence: 99%